<DOC>
	<DOC>NCT00906438</DOC>
	<brief_summary>It is already known from animal studies that the study drug can improve mucosal immunity as shown by increased serum and mucosal IgA secretion. This study will evaluate the safety of an oral intake of the natural product 2006-RD-05 at the recommended daily dose of 300 mg. In addition, this trial will aim to determine if this intake is able ot improve serum and salivary IgA synthesis.</brief_summary>
	<brief_title>Effects of 2006-RD-05 on Salivary and Serum Immunoglobulin A (IgA) Levels in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Men or women aged 18 60 In good health BMI between 20 and 30 kg/m2 Nonsmoking Allergic to study drug Use of immunemodulating drugs Uncontrolled hypertension (Systolic &gt; 140 or diastolic &gt; 90) Women of childbearing age not using proper contraception, that is pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>